Sorrento Therapeutics Inc (SRNEQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRNEQ | AZN | AMGN | GILD | VRTX |
| Company | Sorrento Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0200 | 90.87 | 324.82 | 120.53 | 455.71 |
| High | 0.0310 | 91.13 | 326.03 | 121.64 | 459.05 |
| Low | 0.0200 | 90.19 | 323.02 | 118.17 | 452.83 |
| Latest | 0.0300 | 90.57 | 324.85 | 119.23 | 456.36 |
| Change | +0.0010 | -0.99 | -0.46 | -0.55 | +0.65 |
| % Change | +3.45% | -1.08% | -0.14% | -0.46% | +0.14% |
| Volume | 150,900 | 2,688,327 | 1,146,140 | 2,725,247 | 523,554 |
| 20-Day Average Volume | 202,430 | 5,775,808 | 2,799,733 | 6,954,858 | 1,352,012 |
| Previous Close | 0.0290 | 91.56 | 325.31 | 119.78 | 455.71 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0151 | 90.78 | 332.61 | 123.69 | 439.64 |
| 20-Day Raw Stochastic | 72.97% | 38.36% | 36.08% | 6.43% | 81.35% |
| 20-Day Relative Strength | 53.07 | 56.30 | 51.89 | 44.78 | 60.45 |
| Weighted Alpha | -91.19 | +40.62 | +23.13 | +24.44 | +13.93 |
| Today's Opinion | 64% Sell | 88% Buy | 72% Buy | 56% Buy | 56% Buy |
| Previous Opinion | 64% Sell | 100% Buy | 72% Buy | 56% Buy | 56% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +50.00% since 04/05/24 | +0.82% since 12/09/25 | +3.44% since 12/09/25 | -0.43% since 12/09/25 | +4.21% since 12/09/25 |
| Low | 0.0032 on 04/11/24 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 433.81 on 12/10/25 |
| High | 0.0400 on 04/10/24 | 91.79 on 12/15/25 | 326.03 on 12/16/25 | 123.74 on 12/11/25 | 459.00 on 12/16/25 |
| 1-Month | |||||
| %Chg | +130.77% since 03/12/24 | +1.64% since 11/14/25 | -3.59% since 11/14/25 | -4.94% since 11/14/25 | +4.17% since 11/14/25 |
| Low | 0.0030 on 04/04/24 | 88.41 on 11/20/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 418.53 on 11/19/25 |
| High | 0.0400 on 04/10/24 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | -73.87% since 01/12/24 | +16.76% since 09/16/25 | +18.88% since 09/16/25 | +7.20% since 09/16/25 | +16.36% since 09/16/25 |
| Low | 0.0010 on 01/30/24 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 0.1195 on 01/16/24 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | -77.78% since 10/12/23 | +23.13% since 06/16/25 | +9.84% since 06/16/25 | +7.23% since 06/16/25 | +1.00% since 06/16/25 |
| Low | 0.0010 on 01/30/24 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 0.2495 on 12/22/23 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 16,538 | 283,966,560 | 175,173,264 | 148,608,656 | 115,622,280 |
| Shares Outstanding, K | 551,281 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 62,840,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -572,840,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 15,030,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -95,210,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 2.25 | 0.31 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.17 on 08/11/23 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 05/20/24 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.66 | 14.53 | 14.70 | 29.53 |